Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure (Q44366688)

2 December 2017

Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure (English)

1 reference

2 December 2017

1 reference

6

Gregory Y H Lip

1 reference

2 December 2017

5

Andrew D Blann

1 reference

2 December 2017

Bernard S P Chin

1

1 reference

2 December 2017

Nigel J Langford

series ordinal

2

1 reference

2 December 2017

Sarah L Nuttall

series ordinal

3

1 reference

2 December 2017

Christopher R Gibbs

series ordinal

4

1 reference

2 December 2017

1 March 2003

1 reference

European Journal of Heart Failure

2 December 2017

1 reference

2 December 2017

5

1 reference

2 December 2017

171-174

1 reference

2 December 2017

2

1 reference

Strategies of antioxidant defense

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Free radicals and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

In vivo total antioxidant capacity: comparison of different analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

A reliable marker of endothelial cell dysfunction: does it exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Increased oxidative stress in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Elevated serum antioxidant capacity and plasma malondialdehyde concentration in response to a simulated half-marathon run

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

Mechanisms and implications of endothelial dysfunction in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900251-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S1388-9842(02)00251-9

1 reference

2 December 2017

1 reference